USPTO serial 88450820
PROTAGONIST THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2020
- Examiner
- MURRAY, DAVID T
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PROTAGONIST THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Protagonist Therapeutics, Inc.
Newark, CA, US
Protagonist Therapeutics, Inc.
Newark, CA, US
Protagonist Therapeutics, Inc.
Newark, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Melissa A. Nowak
Melissa A. Nowak Christensen O'Connor Johnson Kindness1201 Third Avenue, Suite 3600Seattle, WA 98101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | SCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; [ TECHNICAL AND SCIENTIFIC CONSULTATION AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS, IN THE FIELD OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES; ] RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND TO PHARMACEUTICALS; PROVIDING ON-LINE INFORMATION FOR MEDICAL RESEARCH PURPOSES, IN THE FIELDS OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, TREATMENTS FOR IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND PHARMACEUTICALS | ACTIVE | May 10, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Protagonist Therapeutics, Inc.
- Other trademarks owned by Protagonist Therapeutics, Inc.
- Other trademarks owned by Protagonist Therapeutics, Inc.
- Other trademarks in Class 042
- Similar marks named PROTAGONIST THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 12, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 12, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 17, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 1, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 28, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 28, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 28, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 28, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 17, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 16, 2021 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jul 7, 2021 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Jul 6, 2021 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Jul 6, 2021 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Jul 6, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 11, 2021 | AMD7 | SEC 7 REQUEST FILED | — |
| Mar 11, 2021 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Sep 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 25, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 24, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 23, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 23, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 2, 2020 | IUAF | USE AMENDMENT FILED | — |
| Jul 2, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 11, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 17, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 17, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Nov 6, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 6, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 21, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 21, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 13, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 1, 2019 | NWAP | NEW APPLICATION ENTERED | — |